Eleven Biotherapeutics (EBIO) Shares Tick Higher Upon Resumption

September 21, 2016 7:34 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Eleven Biotherapeutics (NASDAQ: EBIO) resumes trading. Shares are up nearly 8 percent in premarket action.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Trading Halts

Add Your Comment